Your browser doesn't support javascript.
loading
Incident Type 2 Diabetes Risk of Selective Estrogen Receptor Modulators in Female Patients with Breast Cancer.
Choi, Yeo-Jin; Bak, Keunhyeong; Yeo, Yoon; Choi, Yongwon; Shin, Sooyoung.
Afiliación
  • Choi YJ; Department of Clinical Pharmacy, Graduate School of Clinical Pharmacy, CHA University, Seongnam 13488, Korea.
  • Bak K; Department of Clinical Pharmacy, College of Pharmacy, Ajou University, Suwon 16499, Korea.
  • Yeo Y; Department of Industrial and Physical Pharmacy, College of Pharmacy, Purdue University, West Lafayette, IN 47906, USA.
  • Choi Y; Department of Hematology-Oncology, School of Medicine, Ajou University, Suwon 16499, Korea.
  • Shin S; Department of Clinical Pharmacy, College of Pharmacy, Ajou University, Suwon 16499, Korea.
Pharmaceuticals (Basel) ; 14(9)2021 Sep 14.
Article en En | MEDLINE | ID: mdl-34577625
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: Pharmaceuticals (Basel) Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: Pharmaceuticals (Basel) Año: 2021 Tipo del documento: Article